PRIZE | NAME | TITLE | INSTITUTE |
---|---|---|---|
1 | DR. NITA RADHAKRISHNAN | EFFICACY AND SAFETY OF MIM8 PROPHYLAXIS IN ADULTS AND ADOLESCENTS WITH HEMOPHILIA A WITH OR WITHOUT INHIBITORS: PHASE 3, OPEN LABEL, RANDOMIZED, CONTROLLED FRONTIER2 STUDY | POST GRADUATE INSTITUTE OF CHILD HEALTH, NOIDA |
2 | DR. CHIRASREE SANYAL | A JOURNEY OF HB E BETA THALASSEMIA WITH THALIDOMIDE OVER TIME : THERAPEUTIC BENEFITS, SAFETY AND TOLERABILITY | NRS MEDICAL COLLEGE, KOLKATA |
PRIZE | NAME | TITLE | INSTITUTE |
---|---|---|---|
1 | DR. HEM SUNDER THIRUMURTHY | BAMBO: EMPOWERING SEGMENTATION WITH AN ANNOTATED BONE MARROW BIOPSY DATASET | PGIMER, CHANDIGARH |
2 | DR. HIMIL PARIKH | ANTIPHOSPHATIDYLSERINE/PROTHROMBIN (APS/PT) IGG: A SURROGATE MARKER FOR LUPUS ANTICOAGULANT? | AIIMS, DELHI |
PRIZE | NAME | TITLE | INSTITUTE |
---|---|---|---|
1 | DR. SUVIR SINGH | CLINICAL PROFILE AND OUTCOMES OF HAIRY CELL LEUKEMIA FROM TWO CENTERS IN INDIA: A CALL FOR COLLABORATIVE RESEARCH | DAYANAND MEDICAL COLLEGE, LUDHIANA |
2 | DR. SREYA DAS | OUTCOMES OF DLBCL TREATED FROM 2011 TO 2020: AN AUDIT FROM AN EASTERN INDIA TERTIARY CANCER CENTER | TMC, KOLKATA |
PRIZE | NAME | TITLE | INSTITUTE |
---|---|---|---|
1 | DR. AMRITHA SARAVANAN | THE GENETIC CHARACTERIZATION AND OUTCOME ANALYSIS OF ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE – A GRAY ZONE ENTITY | SGPGI, LUCKNOW |
2 | DR. SHAMBHAVI JHA | BOMBR: A DEEP LEARNING APPROACH BASED DATASET FOR AUTOMATED RETICULIN FIBER DETECTION AND QUANTIFICATION IN BONE MARROW BIOPSIES | PGIMER, CHANDIGARH |
PRIZE | NAME | TITLE | INSTITUTE |
---|---|---|---|
1 | DR. PRATEEK DAS | MOLECULAR LANDSCAPE OF PRECURSOR-T LYMPHOBLASTIC LEUKEMIA: A SINGLE CENTRE EXPERIENCE FROM EASTERN INDIA | TMC, VARANASI |
2 | DR. PRATYUSHA GUDAPATI | MOLECULAR WORK UP OF UNEXPLAINED ERYTHROCYTOSIS IN YOUNG PATIENTS OF INDIAN ORIGIN, A STUDY CONDUCTED AT TERTIARY CENTRE IN NORTH INDIA | AIIMS |